Quality Evaluation System and Key Points for Clinical Selection of Biodiagnostic Reagent Kits

Basic Composition and Classification of Biological Diagnostic Reagent Kits

Biological diagnostic reagent kits generally consist of core reaction reagents, auxiliary reagents, calibrators or quality control materials, as well as necessary consumables and instructions for use. According to detection principles, common categories include immunological detection kits, molecular biology detection kits, biochemical detection kits, and microbiological detection kits. Immunological kits are mostly based on specific antigen-antibody binding and are used to detect protein markers or infection-related antibodies; molecular kits generally achieve analysis of pathogen nucleic acids or gene loci through nucleic acid extraction, amplification, and signal acquisition. Different categories of biological diagnostic reagent kits differ in packaging specifications, storage conditions, and operating procedures, but their common goal is to provide stable and reproducible detection tools for clinical laboratories.

Key Raw Materials and Processes Affecting the Performance of Biological Diagnostic Reagent Kits

The analytical performance of reagent kits is highly dependent on the quality of core raw materials. Taking immunological detection as an example, the affinity, specificity, and batch-to-batch consistency of antibodies or antigens directly affect sensitivity and cross-reactivity; in molecular detection, primer and probe design, enzyme activity, and buffer systems are common factors affecting amplification efficiency and specificity. In terms of production processes, lyophilization, liquid dispensing precision, coating conditions, and blocking steps usually require process validation to ensure consistency between different batches. When raw materials are replaced or processes are changed, re-evaluation of key performance is generally required to confirm that the analytical characteristics of the biological diagnostic reagent kit have not undergone significant drift.

General Requirements for Performance Verification and Quality Control

After biological diagnostic reagent kits enter the laboratory, necessary performance verification usually needs to be carried out in combination with the institution's own detection platform. Common verification indicators include blank limit, detection limit, linear range, precision, accuracy, and anti-interference capability. Precision evaluation generally examines intra-assay and inter-assay variation to reflect the control level of random error and systematic error. Accuracy can be evaluated by comparison with established methods or reference materials. When reagent kits leave the factory, manufacturing enterprises generally provide quality inspection reports, but because different laboratories differ in instruments, personnel, and environment, localized performance confirmation is still recommended. In addition, stability is an important component of quality control, including transport stability, open-vial stability, and real-time stability, among others. Laboratories should store and use the kits according to the conditions specified in the instructions.

Precautions for Selection and Storage in Clinical Laboratories

When selecting biological diagnostic reagent kits, laboratories should first confirm that the product has obtained lawful registration or filing credentials and that its scope of application matches the intended use. Attention should also be paid to the integrity of the kit packaging, expiration date, transport temperature records, and the period of use after opening. For products requiring cold-chain transport, it is recommended to record temperature data upon arrival; for components containing biologically active materials, repeated freezing and thawing should be avoided. During use, procedures should be followed according to the instructions, and the sample type, reaction time, or sample loading volume should not be changed arbitrarily. Calibrators and quality control materials should be reconstituted, aliquoted, and stored according to regulations and incorporated into the daily internal quality control system. If the lot number of a reagent kit is changed, parallel comparison may be performed when conditions permit to reduce the risk of systematic bias.

Conclusion

As an important carrier of in vitro diagnostics, the quality stability and standardized use of biological diagnostic reagent kits directly affect the reliability of detection results. R&D enterprises should continuously improve raw material screening, process control, and quality release standards; clinical laboratories should attach importance to performance verification, cold-chain management, and batch comparison. Only by adhering to scientific evaluation and operation throughout the entire chain can the value of biological diagnostic reagent kits in disease screening, auxiliary diagnosis, and treatment monitoring be fully realized.